- Connect With UsBioscribe is a public relations consultancy dedicated to supporting the communications goals of organizations that are advancing biotechnology, genomics, bioinformatics, molecular diagnostics, and molecular and synthetic biology.Our team members are located in the San Francisco Bay Area, and San Diego and the New York City metropolitan area.
- CapabilitiesMedia Strategy & RelationsPositioning & Messaging, Media Audits, Media Lists, Editorial Calendars, Journalist Outreach, Interview Preparation & Facilitation, Media Training, Coverage MonitoringEditorial Strategy & Content MarketingEditorial Planning, Customer Profiles, Content Development & Editing, Bylined Articles, White Papers, Case Studies, Marketing Collateral, Social Media & Website ContentProduct LaunchesMessaging & Positioning, Publicity Plans, Press Releases, News Distribution, Media Events, Product Placement, Tradeshow SupportBlog & Newsletter ContentEditorial Calendar Planning, Content Development, Managing Approval ProcessThought Leadership & Industry RecognitionPresentation/Talk Development, Op-Eds, Speaking Opportunities, Awards Programs
- OUR CLIENTSIt's The Companies We KeepOur clients are innovative start-ups powering genomics, newly public companies expanding markets, industry associations supporting policy and innovation, incubators of healthcare innovation, and government agencies developing standards.
Advancing molecular diagnosticsBethesda, MDThe Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the growing field of molecular diagnostics.Better tools, faster researchSan Francisco, CABenchling is a privately held company that builds innovative tools to advance biological science and facilitate collaboration by integrating research protocols, experimental results, and data analysis. Benchling believes that knowledge shouldn’t leave the lab when a notebook does, and that eliminating redundant effort and improving access to data will allow science to move faster. Actionable strategies for life sciencesParis, FranceBionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.Enabling high resolution investigation of single cells and limited samplesPalo Alto, CACellular Research is commercializing research products (including Pixel™ a standalone direct mRNA quantitation platform and Precise™ ultra-sensitive high-throughput molecular assays to examine standard or low-input mRNA samples) and partnering with pharmaceutical and diagnostics companies for clinical applications. A shared commitment to creating better health for more peopleMenlo Park, CAHealthymagination is about becoming healthier, through the sharing of imaginative ideas and proven solutions. It goes beyond innovations in the fields of technology and medicine, celebrating the people behind these advancements. Seeking to build stronger relationships between patients and doctors, GE created healthymagination to gather, share and discuss healthy ideas. Powering the synthetic biology revolutionCambridge, MAGen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world's capacity to compile DNA content. Integrating the digital universe of information to better diagnose and treat human diseaseNew York, NYThe Icahn Institute for Genomics and Multiscale Biology at Mount Sinai harnesses "Big Data" analytics to build predictive models that offer novel insights on disease, and they apply these models in a clinical setting to improve diagnosis and treatment for patients. Inspired life science technologyBoulder, COInDevR recently launched the Influenza Titer on Chip® product for rapid quantification of hemagglutinin protein, they key ingredient in flu vaccines. InDevR offers a range of other microarray-related products, including the Vidia™ Microarray Imaging System, the ampliPHOX® Colorimetric Detection platform, and miPLEX™ Custom Arrays to enable our customers a low risk means to explore the high utility of target-specific microarrays. Third-generation DNA sequencingMenlo Park, CAPacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. Better vaccines to better the worldMenlo Park, CAPaxVax is to developing and commercializing innovative vaccines against infectious diseases in a socially responsible manner. Pioneering genome-guided medicineMenlo Park, CAPersonalis, Inc. provides researchers and clinicians advanced genomics sequencing and interpretation services for inherited genetic disease and cancer. The global leader in applications to quickly analyze and interpret genomic dataRedwood City, CAIngenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems. DNA size selection for next-gen sequencingBeverly, MASage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows. Software for scientists and clinicians who work with human genomics dataSan Francisco, CAStation X is the developer of GenePool, a secure SaaS platform that makes big genomics data manageable and meaningful. It greatly simplifies the logistical issues involved in dealing with genomic data and gets actionable information into the hands of biologists and clinicians quickly.Past ClientsSome of our past clients include:Applied Biosystems, BD Biosciences, Biotique Systems, Chiron Corporation, Connetics Corporation, DNAnexus, DoubleTwist, Eos, Genentech, GenoSpectra, IntegenX, Invitrogen, Microsoft Health Solutions, Medtronic, Mohr Davidow Ventures, NanoString Technologies, Nektar, NIST: Multiplexed Biomolecular Science Group, Omicia, PAG, RainDance Technologies, Varian Medical Systems, VitaPath Genetics, Zyomyx - WHO WE ARENicole LitchfieldPresident & CEONicole founded Bioscribe in 1997 in San Francisco to meet the communications needs of the emerging biotech industry. She has 20 years experience providing PR counsel to Fortune 500 companies, small start-ups, and non-profit associations in this industry.Meredith SalisburyDirector, Editorial Content & DevelopmentPrior to joining Bioscribe, Meredith was CEO and Editor-in-Chief of GenomeWeb, the leading news and information service for scientists in the systems biology field.Maurissa MessierDirector, MediaMaurissa brings more than a decade of public relations and marketing communications experience in the life science, pharmaceutical and biotechnology sectors. She has worked both in-house and agency side with small startups to large scale Fortune 500 organizations such as Illumina, Pathway Genomics, and Expression Analysis.Colin SanfordSVP, Client ServicesColin brings to his work more than 20 years of communications experience in the life science, biotechnology and enterprise IT industries. Prior experience includes Vice President at The Corkery Group where he managed communications programs for Gilead Sciences. Prior he served as Director of Marketing Communications at DoubleTwist, an Oakland, Calif.-based genomics company.
- OUR CLIENTS IN THE NEWSHere is a sample of some of the stories we are helping to tell...
